Clinical Trials Logo
  1. Home
  2. HIV
  3. NCT06067646
  4. Details
NCT06067646 Clinical Trial

Optimizing Counceling on Feeding Options of Babies From Mothers Living With HIV

Hiv Clinical Trial

— ROMI  

Official title:
From Guidelines to Clinical Care: What is Needed for Optimizing Counceling on Feeding Options of Babies From Mothers Living With HIV?

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT06067646
Other study ID # 2023-16739
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date January 2024
Est. completion date December 2024

Study information
Verified date September 2023
Source Radboud University Medical Center
Contact Wendy van der Wekken-Pas, MD
Phone +31681485606
Email wendy.vanderwekken-pas@radboudumc.nl
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Semi structured interviews will be performed to determine attitudes and experiences of people living with HIV and health care providers on counseling on feeding options of babies from mothers living with HIV in order to optimize counseling in the future

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 24
Est. completion date December 2024
Est. primary completion date December 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Health care provider involved in care for people living with HIV in Duth HIV treatment facility or - Person living with HIV + age 18-45 + prior pregnancy/desire to have children Exclusion Criteria: - Insufficient command of Dutch or English language (oral)

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Semistructured interview
Semistructured interview and validated quality of life assesment using EQ5-DL

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Radboud University Medical Center

Outcome
Type Measure Description Time frame Safety issue
Primary Experiences and attitudes on subject Experiences and attitudes on subject Explore during semistructured interview during 1 to 2 hours
See also
  Status Clinical Trial Phase
Recruiting NCT06162897 - Case Management Dyad N/A
Completed NCT03999411 - Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients Phase 4
Completed NCT02528773 - Efficacy of ART to Interrupt HIV Transmission Networks
Active, not recruiting NCT05454839 - Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
Recruiting NCT05322629 - Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women N/A
Completed NCT02579135 - Reducing HIV Risk Among Adolescents: Evaluating Project HEART N/A
Active, not recruiting NCT01790373 - Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence N/A
Not yet recruiting NCT06044792 - The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
Completed NCT04039217 - Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM Phase 4
Active, not recruiting NCT04519970 - Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK) N/A
Completed NCT04124536 - Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women N/A
Recruiting NCT05599581 - Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health N/A
Active, not recruiting NCT04588883 - Strengthening Families Living With HIV in Kenya N/A
Completed NCT02758093 - Speed of Processing Training in Adults With HIV N/A
Completed NCT02500446 - Dolutegravir Impact on Residual Replication Phase 4
Completed NCT03805451 - Life Steps for PrEP for Youth N/A
Active, not recruiting NCT03902431 - Translating the ABCS Into HIV Care N/A
Completed NCT00729391 - Women-Focused HIV Prevention in the Western Cape Phase 2/Phase 3
Recruiting NCT05736588 - Elimisha HPV (Human Papillomavirus) N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2